MAPK11 and Huntington disease: We found that MAPK11 knockdown significantly lowered the mHTT-dependent caspase-3 activation under this condition, suggesting that lowering MAPK11 ameliorates mHTT toxicity in HD patient iPSC-derived neurons (Figure 8A).